Executive Summary
Leidos dominates with a $1.06B SSA IT contract (37% of total value), signaling robust civilian IT demand and multi-year revenue stability amid $2.9B in awards. DHS/CBP and VA drive security/IT and medical supply contracts, with 16/18 bullish signals highlighting long-term options worth $2B+ upside. Firm fixed price structures prevail (70% of contracts), exposing winners to cost risks but locking in predictable cash flows through 2026-2033.
Tracking the trend? Catch up on the prior General Federal Contracts digest from March 17, 2026.
Investment Signals(4)
- Leidos secures mega SSA IT award(HIGH)▲
$1.06B obligation (base+options $1.20B) for IT management, 82% outlayed, extends to 2028 potential.
- DHS/CBP border security equipment boom(HIGH)▲
$410M+ across Rapiscan, Smiths Detection, Leidos, Steampunk for detection/maintenance, long horizons to 2031-2033.
- VA health IT/supplies pipeline accelerates(MEDIUM)▲
$450M+ in Oracle, Medline (x2), Deloitte for EHR/interfaces and prime vendor, options up to $1B+ total.
- HHS/CMS stable healthcare services(HIGH)▲
$415M+ Wisconsin Physicians, Charles River for MAC/ animal care, cost-plus structures to 2028-2029.
Risk Flags(3)
- Execution[HIGH RISK]▼
Firm fixed price in 70% of contracts risks cost overruns on long-term deliveries (e.g., Leidos SSA, Rapiscan portals to 2033).
- Market[MEDIUM RISK]▼
Options unexercised in 12/18 contracts cap upside at $2B+ (e.g., Oracle VA $607M potential).
- Competitive[MEDIUM RISK]▼
Non-competed awards (25%) like Leidos DHS/VA signal sole-source dependency, vulnerable to future rebids.
Opportunities(3)
- ◆
$1.5B+ in unexercised options across IT/health contracts (e.g., Salient HUD $150M+ upside).
- ◆
Extensions to 2029-2033 in 40% of awards (DHS Rapiscan/Smiths, GSA Life Science).
- ◆
High outlays (avg 45% obligated value executed) indicate low cancellation risk (e.g., Leidos SSA 82%).
Sector Themes(3)
- ◆
65% of value ($1.9B) in NAICS 5415xx for civilian/defense IT (SSA, HUD, VA, DHS), full/open competition wins.
- ◆
$500M+ in detection/maintenance/HR IT for CBP/USCIS, extending to 2031+.
- ◆
$206M Medline prime vendor for 2026 months signals monthly cadence.
Watch List(4)
- 👁
{"entity"=>"Leidos (LDOS)", "reason"=>"$1.13B across SSA/DHS (39% total value), $183M DHS options upside.", "trigger"=>"Q1 2026 option exercises or outlay acceleration"}
- 👁
{"entity"=>"Oracle Health (ORCL)", "reason"=>"$176M VA EHRM obligated, $607M options in non-competed health IT.", "trigger"=>"Initial outlays post-$0 current; follow-on VA awards"}
- 👁
{"entity"=>"Medline Industries", "reason"=>"Back-to-back $138M VA 2026 supply orders indicate recurring prime vendor.", "trigger"=>"March 2026 outlays confirming monthly pattern"}
- 👁
{"entity"=>"DHS CBP IT/Equipment Awards", "reason"=>"$400M+ cluster across 5 firms, long extensions possible.", "trigger"=>"New FY2027 task orders or extensions to 2030+"}
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 18 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC